Topical and Nasal AOD-9604 Topical and nasal forms appear in marketing, but the FDA review found no published human exposure data for transdermal or intranasal AOD-9604
Two recent clinical studies also reported remarkably upregulated PPAR expression in red blood cells, boosted serum GSH and GPX levels and decreased serum MAD contents after treatment with curcumin (500 mg/day, P.O for 8 weeks
Lancet Diabetes Endocrinol 3(3):181190 Dehnavi S, Sohrabi N, Sadeghi M, Lansberg P, Banach M, Al-Rasadi K, Johnston TP, Sahebkar A (2020) Statins and autoimmunity: state-of-the-art
The code can be quite helpful in handling any condition that is similar to arthritis, bursitis, or gout for pain relief, and inflammation may be reduced as well